Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Albumin and Prognosis of Severely Patients Burns

View source ↗

Summary

This clinical trial evaluates whether albumin improves prognosis in patients with severe burn injuries and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Serum Albumin (human serum albumin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Burn | Status: RECRUITING